Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
Published in
Journal of Investigative Dermatology, September 2020
Pharmacology, Toxicology and Pharmaceutical Science
3
7%
Agricultural and Biological Sciences
2
5%
Unspecified
1
2%
Other
2
5%
Unknown
24
57%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2025.
All research outputs
#2,736,941
of 32,440,831 outputs
Outputs from Journal of Investigative Dermatology
#759
of 10,814 outputs
Outputs of similar age
#57,063
of 446,418 outputs
Outputs of similar age from Journal of Investigative Dermatology
#11
of 96 outputs
Altmetric has tracked 32,440,831 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,814 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,418 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.